Search

everythinglearnresearchcommunity

for

Search:↓

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Suppressing certain hormones might help prevent prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride increases hair weight and count in men with hair loss, with best results after four years.

Finasteride increases hair weight and count in men with hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.